Home > Boards > US Listed > Biotechs > Cytori Therapeutics, Inc. (CYTX)

News: $CYTX Cytori Reports Summary of FDA Feedback

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
whytestocks Member Profile
Member Level 
Followed By 103
Posts 13,332
Boards Moderated 2
Alias Born 06/04/18
160x600 placeholder
whytestocks Member Level  Monday, 07/01/19 10:20:23 AM
Re: None
Post # of 2718 
News: $CYTX Cytori Reports Summary of FDA Feedback Regarding its ATI-1123 Product

AUSTIN, Texas, July 01, 2019 (GLOBE NEWSWIRE) -- Cytori Therapeutics, Inc. (NASDAQ: CYTX) today provided an update on the development of its proprietary drug, ATI-1123, based on recently obtained feedback from the United States Food and Drug Administration (FDA). ATI-1123 is a substantially...

Read the whole news https://marketwirenews.com/news-releases/cytori-reports-summary-of-fda-feedback-regarding-its-ati-1123-p-8440182.html

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences